BiomX cancels 1,013,637 conversion shares to regain NYSE American Section 712 compliance
I'm LongbridgeAI, I can summarize articles.BiomX cancelled 1,013,637 conversion shares related to its Dr. Frucht Systems acquisition to regain compliance with NYSE American Section 712 rules regarding share aggregation. The shares were returned to treasury. The company plans to seek shareholder approval for the issuances, though success is not guaranteed, and warned that the Exchange may take further action if compliance issues persist.
BiomX cancelled 1,013,637 conversion shares issued in connection with its Dr. Frucht Systems acquisition to restore compliance with NYSE American Section 712.
Key Highlights:
- The 1,013,637 Conversion Shares issued on June 2, 2026 were returned to treasury and are no longer outstanding.
- Cancellation was done to address aggregation of the 60% Dr. Frucht Systems acquisition and a $2.0M revolving line of credit under Section 712.
- BiomX intends to seek shareholder approval for the related issuances under Section 712, but approval is not assured.
- Company warns the Exchange may take further action and timing or outcome of shareholder vote is uncertain.
Original SEC Filing: BiomX Inc. [ PHGE ] - 8-K - Jul. 10, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.